Relentless Health Value cover image

EP448 (Part 1): 340B: Where It Started, Where It Is Now, and Who Is Really Benefiting From This Massive Program, With Shawn Gremminger

Relentless Health Value

00:00

Charity Care and the 340B Dilemma

This chapter investigates the ambiguous definition of charity care in healthcare and its implications for the 340B drug pricing program. It raises concerns about transparency and effectiveness amid significant financial growth, suggesting that the original purpose of the program may not be achieved.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app